1. Lysosomotropic agents;C, De Duve; T, De Barsy; B, Poole; A, Trouet; P, Tulkens; F, Van Hoof;Biochem Pharmacol,1974
2. Targeting of drugs;Gregoriadis, G.;Nature,1977
3. Targeting of antiviral drugs by coupling with protein carriers;Fiume, L.; Busi, C.; Mattioli, A.;FEBS Lett,1983
4. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine;Chadwick, R.G.; Bassendine, M.F.; Crawford, E.M.; Thomas, H.C.; Sherlock, S.;Br Med J,1978
5. Effect of vidarabine on chronic hepatitis B virus infection;Pollard, R.B.; Smith, J.L.; Neal, E.A.; Gregory, P.B.; Merigan, T.C.; Robinson, W.S.;JAMA,1978